Product Information
LORAZEPAM 2 MG/ML ORAL CONCENT is a generic product labeled by Chartwell RX LLC, priced at $0.6863 per ML under NDC 62135054943. Its NADAC has been published 114 times since Jul 31, 2024.
FDA first approved this application on Apr 28, 2009.
Strength
2 mg/mL
Manufacturer
Chartwell RX LLCNDC
62135054943
Classification
Generic
Dosage Form
CONCENTRATE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LORAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA079244FDA Approved
4/28/2009
On Market Since
4/28/2009
Pharmacological Classes
Price Statistics
The NADAC for LORAZEPAM 2 MG/ML ORAL CONCENT has been published 114 times since Jul 31, 2024, and over the history we have for it it has risen 27.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6863 per ML |
|---|---|
| All-time high | $0.6928 (Sep 16, 2026) |
| All-time low | $0.5405 (Jul 31, 2024) |
| 52-week high | $0.6928 |
| 52-week low | $0.6214 |
| Median price | $0.6331 |
| Average price | $0.6265 |
| Largest weekly change | +13.6% (Aug 21, 2024) |
| Weeks tracked | 114 |
| Tracking since | Jul 31, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chartwell RX LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Lorazepam market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Benzodiazepine class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LORAZEPAM 2 MG/ML ORAL CONCENT?
The current National Average Drug Acquisition Cost (NADAC) for LORAZEPAM 2 MG/ML ORAL CONCENT, manufactured by Chartwell RX LLC, is $0.6863 per ML (NDC 62135054943), effective Sep 30, 2026.
How has the price of LORAZEPAM 2 MG/ML ORAL CONCENT changed over time?
Over the history we have for it, the NADAC for LORAZEPAM 2 MG/ML ORAL CONCENT has risen 27.0%. It has been tracked across 114 weekly CMS publications since Jul 31, 2024.
What are the highest and lowest recorded NADAC prices for LORAZEPAM 2 MG/ML ORAL CONCENT?
Since Jul 31, 2024, the NADAC for LORAZEPAM 2 MG/ML ORAL CONCENT has ranged from a low of $0.5405 (Jul 31, 2024) to a high of $0.6928 (Sep 16, 2026), with a median of $0.6331 per ML.
Are there cheaper alternatives to LORAZEPAM 2 MG/ML ORAL CONCENT?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as LORAZEPAM 2 MG/ML ORAL CONCENT in a comparable dosage form, but none are currently priced below it.
Who manufactures LORAZEPAM 2 MG/ML ORAL CONCENT?
LORAZEPAM 2 MG/ML ORAL CONCENT (NDC 62135054943) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.